Home»Research Audit and Clinical Practice»The prognostic efficacy of beta2-microglobulin in acute pulmonary embolism

The prognostic efficacy of beta2-microglobulin in acute pulmonary embolism


Our aim was to prospectively assess the prognostic value of beta2- microglobulin (b2-M) in patients with acute pulmonary embolism (PE). We conducted a prospective study of 109 patients admitted in a pulmonary clinic due to acute PE. A panel of inflammatory markers including b2-M white blood cell (WBC) count and C-reactive protein (CRP)…

Please log in or register to see more.
Log In Register
Authors: , , , ,
Reference:

Previous post

Predicting length of stay for acute medical admissions using the ALICE score: a simple bedside tool

Next post

Editorial Volume 16 Issue 2